Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiangju tablets for seasonal allergic rhinitis
ChiCTR2300075873Phase 4Recruiting
- Sponsor
- Inner Mongolia Hospital of Traditional Chinese Medicine
- Start
- Sep 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xiangju in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Inner Mongolia Hospital of Traditional Chinese Medicine. Primary endpoint: Total nasal symptom score. Started Sep 2023; status: recruiting.
02
Drugs
Xiangju
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ChiCTR2300075873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075873.